Auna Performance degli utili passati
Criteri Il passato verificati 1/6
Auna ha registrato una crescita degli utili a un tasso medio annuo di 20.7%, mentre il settore Healthcare ha registrato utili in crescita a un tasso medio annuo di 4%. I ricavi sono stati in crescita a un tasso medio annuo di 21.2%. Il ritorno sul capitale proprio di Auna è 4.3% e ha margini netti di 1.5%.
Informazioni chiave
20.74%
Tasso di crescita degli utili
12.99%
Tasso di crescita dell'EPS
| Healthcare Crescita del settore | 8.50% |
| Tasso di crescita dei ricavi | 21.24% |
| Rendimento del capitale proprio | 4.30% |
| Margine netto | 1.52% |
| Ultimo aggiornamento sugli utili | 31 Mar 2026 |
Aggiornamenti sulle prestazioni recenti
Recent updates
Aggiornamento narrativa • Jun 29
AUNA: Lowered Price View And 2026 Guidance Will Frame Execution Risks
Analysts have reduced their price target on Auna to $5 from $6, citing lowered estimates following a worse-than-expected Q1 report. What’s in the News for Auna Auna reaffirmed its earnings guidance for 2026, indicating that its full-year outlook for that period remains unchanged.
Aggiornamento narrativa • Jun 15
AUNA: Reaffirmed 2026 Guidance Will Challenge Bearish Reset After Q1 Setback
Analysts have trimmed their view on Auna, with the consensus price target moving down by $1 to $5, citing weaker than expected Q1 results and lower company estimates. What's in the News Auna reaffirmed earnings guidance for 2026, maintaining its outlook for the full year.
Aggiornamento narrativa • Jun 01
AUNA: Mexico Execution And 2026 Guidance Will Drive Bullish Re Rating
Analysts have reduced their price target on Auna by $1 to $5, reflecting updated assumptions for fair value, discount rate, growth, margins, and future P/E following a worse than expected Q1 report. What's in the News Auna issued new earnings guidance for fiscal year 2026, projecting revenue growth of about 12% on a constant currency basis, within a range of 10% to 14%.Seeking Alpha • May 29
Auna: A Discounted Hospital Operator With An Insurance Twist
Summary Auna trades at depressed valuations despite a stable, integrated insurance and hospital business spanning Peru, Colombia, and Mexico. Operational setbacks in Mexico and Colombia have pressured results, but recent management actions and Q1 trends indicate stabilization and recovery potential. AUNA’s leverage remains high (net debt/EBITDA 3.7x), but recent debt restructuring, improved cash generation, and reduced capex support deleveraging. With a P/FCF of 1.9x and P/E of 5x (2026E), AUNA offers material upside if operational and macro risks continue to abate. Read the full article on Seeking AlphaArticolo di analisi • May 28
Some Investors May Be Willing To Look Past Auna's (NYSE:AUNA) Soft Earnings
Investors were disappointed with the weak earnings posted by Auna S.A. ( NYSE:AUNA ). Despite the soft profit numbers...Aggiornamento narrativa • May 04
AUNA: Execution On 2026 Guidance Will Drive Reassessment Of Bearish Reset
Analysts have reduced their price target on Auna from $19.00 to $9.00, citing updated assumptions for discount rate, revenue growth, profit margins, and a lower future P/E following recent bearish Street research. Analyst Commentary Even with the lower headline target, some bullish analysts still see room for upside if Auna can deliver on key execution milestones and support the revised valuation assumptions.Aggiornamento narrativa • Apr 19
AUNA: Mexico Execution And 2026 Guidance Will Support Bullish Re‑Rating
Analysts have maintained their price target on Auna at $7.20, citing a mix of more cautious and more optimistic research views that reflect slightly updated assumptions for discount rates, growth and P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts point to the current $7.20 target as reasonable relative to their updated P/E assumptions, suggesting the valuation still lines up with their expectations for the business model and capital allocation.Aggiornamento narrativa • Apr 05
AUNA: Mexico Execution And 2026 Guidance Will Support Long-Term Upside
Analysts have trimmed their price target for Auna from about $10.42 to $7.20, reflecting updated views on discount rates, revenue growth, profit margins and future P/E, following a mix of recent bullish and bearish research updates. Analyst Commentary Recent research on Auna shows a mix of optimism and caution, which helps explain the reduced price target and the current debate around the shares.Aggiornamento narrativa • Mar 22
AUNA: Mixed Research Views And 2026 Guidance Will Shape Execution Outlook
Auna's analyst price target has been updated to $6.00, with analysts citing mixed recent research that includes a more cautious stance from BTG Pactual, along with more constructive views from HSBC and Jefferies on the company outlook. Analyst Commentary Recent Street research on Auna points to a split view, with some analysts turning more constructive while others are sounding more cautious and adjusting ratings and price targets accordingly.Aggiornamento narrativa • Mar 08
AUNA: Execution On Mixed Research Views Will Shape Future Upside Potential
Analysts have trimmed their Auna price target to $6.00, reflecting slightly adjusted assumptions around the discount rate, revenue growth, profit margins and future P/E after a mix of more cautious and more constructive recent research views. Analyst Commentary Recent research views on Auna have moved in different directions, with some firms turning more constructive and at least one becoming more cautious.Aggiornamento narrativa • Feb 22
AUNA: Execution On Mixed Mexico Expansion Views Will Drive Future Upside
Analysts have nudged their price target on Auna up from $6.00 to $6.50, reflecting mixed but generally constructive research, with one firm turning more cautious even as others highlight potential for slightly better growth, margins, and a lower assumed future P/E. Analyst Commentary Recent research has not been uniformly positive, and some bearish analysts are clearly leaning more cautious on Auna, even as others highlight potential upside.Aggiornamento narrativa • Feb 07
AUNA: Mexico Expansion And Leverage Execution Will Drive Upside Potential
Analysts have reduced their price target on Auna to $6.00 from $13.50, reflecting a more cautious stance as they weigh concerns about a slower ramp up in Mexico, elevated leverage, and mixed recent rating changes from BTG Pactual, HSBC, and Jefferies. Analyst Commentary Recent research shows a split in views on Auna, with some firms taking a more constructive stance while others highlight execution and balance sheet risks.Aggiornamento narrativa • Jan 24
AUNA: Mexico Execution And Leverage Path Will Shape Balanced Upside Potential
Analysts have lifted their Auna price target to $6.00 from $6.00, keeping the fair value level steady while adjusting their view to reflect updated assumptions on discount rates, revenue growth, profit margins and future P/E in light of mixed but generally constructive recent research. Analyst Commentary Recent research on Auna has been mixed, with some firms taking a more constructive stance while others highlight ongoing execution and balance sheet questions.Articolo di analisi • Jan 23
Does Auna (NYSE:AUNA) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Aggiornamento narrativa • Jan 10
AUNA: Mexico Expansion Will Reframe Perceived Execution And Leverage Risks
Analysts have trimmed their price target on Auna to US$6 from US$13.50, pointing to a slower ramp-up in Mexico, a less supportive consolidated growth profile, and expectations that leverage will remain elevated. Analyst Commentary Recent Street research on Auna has turned more cautious, with JPMorgan cutting its rating to Neutral and lowering its price target to US$6 from US$13.50.Aggiornamento narrativa • Dec 22
AUNA: Mexico Execution And Deleveraging Will Drive Long-Term Upside Potential
Analysts have trimmed their price target on Auna by roughly $0.25 to reflect a slightly lower fair value estimate and a modestly higher discount rate, citing concerns over slower than expected growth and sustained leverage highlighted in recent research. Analyst Commentary Analyst reactions to the latest developments at Auna have focused on the trade off between long term growth optionality and near term execution risks, particularly around the company's regional expansion and balance sheet trajectory.Aggiornamento narrativa • Dec 08
AUNA: Mexico Expansion And Deleveraging Will Unlock Future Upside Potential
Analysts have lowered their price target on Auna from $13.50 to $6.00, citing a slower than expected ramp-up in Mexico, a less compelling consolidated growth profile, and persistently elevated leverage. Analyst Commentary Analyst views on Auna have turned more cautious following the recent downgrade and target price cut to $6.00, but the stock’s reset valuation is also seen as creating a more balanced risk reward profile.Aggiornamento narrativa • Nov 24
AUNA: Future Expansion Plans In Mexico Will Unlock Growth Potential
Narrative Update: Analyst Price Target Change for Auna The average analyst price target for Auna was reduced from $12.08 to $10.67. Analysts point to a slower than expected operational ramp-up and persistent elevated leverage as key factors for the adjustment.Articolo di analisi • Nov 14
Auna (NYSE:AUNA) Is Looking To Continue Growing Its Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...Nuova narrativa • May 29
High-Efficiency Healthcare Model And Demographic Trends Will Shape Future Landscape
Operational challenges in Mexico are being addressed, while strong performance in Peru showcases the potential of Auna's value-based, integrated care model.Articolo di analisi • Jan 29
A Piece Of The Puzzle Missing From Auna S.A.'s (NYSE:AUNA) 26% Share Price Climb
The Auna S.A. ( NYSE:AUNA ) share price has done very well over the last month, posting an excellent gain of 26%. While...Articolo di analisi • Jan 19
Here's Why Auna (NYSE:AUNA) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Seeking Alpha • Jan 15
Auna: Cheap Entry Level In Latin American Healthcare Play
Summary Auna is a leading player in the Spanish-speaking Latin America medical industry, focusing particularly on high-complexity diseases, such as cancer. Most SSLA have a highly fragmented and underserved healthcare market, and populations are becoming elderly, demanding more and better services. AUNA stock has been impacted negatively following its IPO process, as local institutional players such as pension funds overbought the stock and had to sell due to regulatory limits. AUNA stock trades currently below 6X EV / EBITDA, while revenues and EBITDA are growing at double digits. Patient investors should benefit from valuation normalization metrics and continued growth. Though it still has high leverage (Net Debt / EBITDA =3.7), it has been able to decrease it (from 6.8X in 2021) and has stable and growing operating cash flows (annual run rate USD250MM last quarter). Interest rate reductions should benefit the company. Read the full article on Seeking AlphaRipartizione dei ricavi e delle spese
Ripartizione dei ricavi e delle spese
Come Auna guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.
Storico di utili e ricavi
| Data | Ricavi | Utili | Spese G+A | Spese di R&S |
|---|---|---|---|---|
| 31 Mar 26 | 4,521 | 69 | 1,115 | 0 |
| 31 Dec 25 | 4,385 | 98 | 1,082 | 0 |
| 30 Sep 25 | 4,316 | 187 | 1,042 | 0 |
| 30 Jun 25 | 4,325 | 237 | 1,053 | 0 |
| 31 Mar 25 | 4,352 | 159 | 1,035 | 0 |
| 31 Dec 24 | 4,386 | 110 | 1,027 | 0 |
| 30 Sep 24 | 4,344 | -123 | 1,006 | 0 |
| 30 Jun 24 | 4,233 | -261 | 964 | 0 |
| 31 Mar 24 | 4,058 | -263 | 956 | 0 |
| 31 Dec 23 | 3,876 | -254 | 902 | 0 |
| 30 Sep 23 | 3,659 | -112 | 836 | 0 |
| 30 Jun 23 | 3,241 | -76 | 769 | 0 |
| 31 Mar 23 | 2,861 | -100 | 674 | 0 |
| 31 Dec 22 | 2,452 | -86 | 620 | 0 |
| 30 Sep 22 | 2,118 | -65 | 626 | 0 |
| 30 Jun 22 | 2,009 | -64 | 604 | 0 |
| 31 Mar 22 | 1,937 | -35 | 594 | 0 |
| 31 Dec 21 | 1,924 | -26 | 586 | 0 |
| 30 Sep 21 | 1,874 | 20 | 536 | 0 |
| 30 Jun 21 | 1,779 | 42 | 494 | 0 |
| 31 Mar 21 | 1,577 | 51 | 449 | 0 |
| 31 Dec 20 | 1,444 | -7 | 421 | 0 |
| 30 Sep 20 | 1,373 | 28 | 396 | 0 |
| 30 Jun 20 | 1,335 | 14 | 388 | 0 |
| 31 Mar 20 | 1,381 | 16 | 385 | 0 |
| 31 Dec 19 | 1,383 | 73 | 375 | 0 |
| 31 Dec 18 | 861 | 36 | 271 | 0 |
| 31 Dec 17 | 723 | 22 | 244 | 0 |
Guadagni di qualità: AUNA ha un grande una tantum perdita di PEN63.1M che ha avuto un impatto sui suoi ultimi 12 mesi di risultati finanziari pari a 31st March, 2026.
Margine di profitto in crescita: Gli attuali margini di profitto netti di AUNA (1.5%) sono inferiori rispetto allo scorso anno (3.7%).
Flusso di cassa libero e analisi degli utili
Analisi della crescita degli utili nel passato
Andamento degli utili: AUNA è diventata redditizia negli ultimi 5 anni, aumentando i guadagni del 20.7% all'anno.
Accelerare la crescita: AUNA ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.
Guadagni vs Settore: AUNA ha avuto una crescita negativa degli utili ( -56.8% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Healthcare ( 15.3% ).
Rendimento del capitale proprio
ROE elevato: Il Return on Equity ( 4.3% ) di AUNA è considerato basso.
Rendimento delle attività
Rendimento del capitale investito
Scoprire le aziende con forti performance passate
Analisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/07/13 04:47 |
| Prezzo dell'azione a fine giornata | 2026/07/13 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Auna S.A. è coperta da 7 analisti. 7 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Samuel Campos Alves | BTG Pactual |
| Leandro Bastos | Citigroup Inc |
| Raj Sinha | HSBC |